Indoco Remedies (INDOCO.NS) Earnings Analysis
Indoco Remedies (INDOCO.NS) has no confirmed upcoming earnings date. Last quarter (2026-05-07) it beat with EPS -2.45 INR vs -3.55 INR est (+31%). It has beaten estimates in 1/6 recent quarters (17%). Trailing P/E -22.20.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does INDOCO.NS next report earnings?
No confirmed upcoming earnings date is currently scheduled for INDOCO.NS. This page updates as the calendar is published.
INDOCO.NS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -2.45 INR | -3.55 INR | +31% | Beat |
| 2025-07-21 | -3.94 INR | -3 INR | -31.3% | Miss |
| 2025-05-22 | -4.48 INR | -3.6 INR | -24.4% | Miss |
| 2025-01-21 | -3.05 INR | -1.5 INR | -103.3% | Miss |
| 2024-10-24 | -1.03852 INR | 1.75 INR | -159.3% | Miss |
| 2024-07-23 | 0.2842 INR | 1.1 INR | -74.2% | Miss |
Beat rate: 1/6 (17%) over reported quarters with consensus data.
INDOCO.NS valuation and analyst view
| Trailing P/E | -22.20 |
|---|---|
| Trailing EPS | -11.54248 INR |
| Price / book | 2.14 |
| Dividend yield | 0.08% |
| Market cap | 21.49B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Indoco Remedies (INDOCO.NS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for INDOCO.NS. This page updates as the calendar is published.
Did INDOCO.NS beat earnings last quarter?
In its 2026-05-07 report, INDOCO.NS posted EPS of -2.45 INR versus a -3.55 INR estimate — a beat of 31%.
What is INDOCO.NS's earnings track record?
Over the last 6 reported quarters with consensus data, INDOCO.NS beat estimates 1 times (17%).
What is INDOCO.NS's current P/E ratio and EPS?
INDOCO.NS trades at a trailing P/E of -22.20 on trailing EPS of -11.542481176219091 INR.
What do analysts rate INDOCO.NS?
INDOCO.NS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.